Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A prospective study of venous thromboembolism after major trauma.
Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. Geerts WH, et al. Among authors: jay rm. N Engl J Med. 1994 Dec 15;331(24):1601-6. doi: 10.1056/NEJM199412153312401. N Engl J Med. 1994. PMID: 7969340
An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery.
Cruickshank MK, Levine MN, Hirsh J, Turpie AG, Powers P, Jay R, Gent M. Cruickshank MK, et al. Thromb Haemost. 1989 Nov 24;62(3):830-4. Thromb Haemost. 1989. PMID: 2595657
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Turpie AG, Gent M, Côte R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J, et al. Turpie AG, et al. Ann Intern Med. 1992 Sep 1;117(5):353-7. doi: 10.7326/0003-4819-117-5-353. Ann Intern Med. 1992. PMID: 1503326 Clinical Trial.
A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.
Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA, Hamilton PA. Geerts WH, et al. Among authors: jay rm. N Engl J Med. 1996 Sep 5;335(10):701-7. doi: 10.1056/NEJM199609053351003. N Engl J Med. 1996. PMID: 8703169 Clinical Trial.
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Gent M, Hirsh J, Ginsberg JS, Powers PJ, Levine MN, Geerts WH, Jay RM, Leclerc J, Neemeh JA, Turpie AG. Gent M, et al. Among authors: jay rm. Circulation. 1996 Jan 1;93(1):80-4. doi: 10.1161/01.cir.93.1.80. Circulation. 1996. PMID: 8616946 Clinical Trial.
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, Rosenbloom D, Sackett DL, Anderson C, Harrison L, et al. Hull RD, et al. Among authors: jay rm. N Engl J Med. 1986 Oct 30;315(18):1109-14. doi: 10.1056/NEJM198610303151801. N Engl J Med. 1986. PMID: 3531862 Clinical Trial.
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. Turpie AG, et al. Among authors: jay rm. N Engl J Med. 1986 Oct 9;315(15):925-9. doi: 10.1056/NEJM198610093151503. N Engl J Med. 1986. PMID: 3531851 Clinical Trial.
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Powers PJ, Gent M, Jay RM, Julian DH, Turpie AG, Levine M, Hirsh J. Powers PJ, et al. Among authors: jay rm. Arch Intern Med. 1989 Apr;149(4):771-4. Arch Intern Med. 1989. PMID: 2650646 Clinical Trial.
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, Turpie AG, McLoughlin D, Dodd P, Thomas M, Raskob G, Ockelford P. Hull R, et al. N Engl J Med. 1982 Dec 30;307(27):1676-81. doi: 10.1056/NEJM198212303072704. N Engl J Med. 1982. PMID: 6755255 Clinical Trial.
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R, Gent M. Turpie AG, et al. Chest. 1990 Apr;97(4 Suppl):172S-175S. Chest. 1990. PMID: 2108855 Clinical Trial.
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback